Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea

This paper provides a review of the largest studies (over the period of 2017 to 2022) on the use of fecal microbiota transplantation (FMT) for the treatment of patients with recurrent Clostridioides difficileassociated diarrhea (CDAD), including pseudomembranous colitis. A focus was made on methods...

Full description

Bibliographic Details
Main Author: Ortenberg E.A.
Format: Article
Language:Russian
Published: Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2022-12-01
Series:Клиническая микробиология и антимикробная химиотерапия
Subjects:
Online Access:https://cmac-journal.ru/publication/2022/4/cmac-2022-t24-n4-p308/cmac-2022-t24-n4-p308.pdf
_version_ 1797866646604349440
author Ortenberg E.A.
author_facet Ortenberg E.A.
author_sort Ortenberg E.A.
collection DOAJ
description This paper provides a review of the largest studies (over the period of 2017 to 2022) on the use of fecal microbiota transplantation (FMT) for the treatment of patients with recurrent Clostridioides difficileassociated diarrhea (CDAD), including pseudomembranous colitis. A focus was made on methods of preparation and administration of fecal microbiota product. The recent systematic reviews and metaanalyses consistently consider TFM as an effective treatment option for recurrent CDAD. The different methods of fecal microbiota preparation and administration (fresh, frozen, lyophilized) show similar efficacy but differ by convenience of use.
first_indexed 2024-04-09T23:28:44Z
format Article
id doaj.art-9067760ea6d548518c065837a3354913
institution Directory Open Access Journal
issn 1684-4386
2686-9586
language Russian
last_indexed 2024-04-09T23:28:44Z
publishDate 2022-12-01
publisher Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
record_format Article
series Клиническая микробиология и антимикробная химиотерапия
spelling doaj.art-9067760ea6d548518c065837a33549132023-03-21T08:26:14ZrusInterregional Association for Clinical Microbiology and Antimicrobial ChemotherapyКлиническая микробиология и антимикробная химиотерапия1684-43862686-95862022-12-0124430831310.36488/cmac.2022.4.308-313cmac-2022-t24-n4-p308Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrheaOrtenberg E.A.0Tyumen State Medical University, Tyumen, RussiaThis paper provides a review of the largest studies (over the period of 2017 to 2022) on the use of fecal microbiota transplantation (FMT) for the treatment of patients with recurrent Clostridioides difficileassociated diarrhea (CDAD), including pseudomembranous colitis. A focus was made on methods of preparation and administration of fecal microbiota product. The recent systematic reviews and metaanalyses consistently consider TFM as an effective treatment option for recurrent CDAD. The different methods of fecal microbiota preparation and administration (fresh, frozen, lyophilized) show similar efficacy but differ by convenience of use.https://cmac-journal.ru/publication/2022/4/cmac-2022-t24-n4-p308/cmac-2022-t24-n4-p308.pdfclostridioides difficileantibiotic-associated diarrheapseudomembranous colitistreatmentfecal microbiota transplantation
spellingShingle Ortenberg E.A.
Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
Клиническая микробиология и антимикробная химиотерапия
clostridioides difficile
antibiotic-associated diarrhea
pseudomembranous colitis
treatment
fecal microbiota transplantation
title Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
title_full Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
title_fullStr Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
title_full_unstemmed Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
title_short Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
title_sort fecal microbiota transplantation as a treatment option for patients with recurrent clostridioides difficile associated diarrhea
topic clostridioides difficile
antibiotic-associated diarrhea
pseudomembranous colitis
treatment
fecal microbiota transplantation
url https://cmac-journal.ru/publication/2022/4/cmac-2022-t24-n4-p308/cmac-2022-t24-n4-p308.pdf
work_keys_str_mv AT ortenbergea fecalmicrobiotatransplantationasatreatmentoptionforpatientswithrecurrentclostridioidesdifficileassociateddiarrhea